CNS progression during vinblastine or targeted therapies for high-risk relapsed ALK-positive anaplastic large cell lymphoma: A case series-Reference-Cited by-同舟云学术

CNS progression during vinblastine or targeted therapies for high-risk relapsed ALK-positive anaplastic large cell lymphoma: A case series

Published:2018-03-07 Issue:6 Volume:65 Page:e27003
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Ruf Stephanie¹^ORCID,Hebart Holger²,Hjalgrim Lisa Lyngsie³,Kabickova Edita⁴,Lang Peter⁵,Steinbach Daniel⁶,Schwabe Georg C.⁷,Woessmann Wilhelm¹

Affiliation:

1. Department of Pediatric Hematology and Oncology; Justus Liebig University Giessen; Giessen Germany

2. Department of Internal Medicine; Stauferklinikum Schwaebisch Gmuend; Mutlangen Germany

3. The Child and Youth Clinic; Department of Pediatric Hematology and Oncology; University Hospital Copenhagen; Copenhagen Denmark

4. Department of Pediatric Hematology and Oncology; Charles University and University Hospital Motol; Prague Czech Republic

5. Department of Pediatric Hematology and Oncology; Eberhard Karls University Tuebingen; Tuebingen Germany

6. Department of Pediatric Hematology and Oncology; University Hospital Ulm; Ulm Germany

7. Children's Hospital Cottbus; Cottbus Germany

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.27003/fullpdf

Reference26 articles.

1. Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-Muenster (BFM)-type first-line therapy: a BFM-group study;Woessmann;J Clin Oncol,2011

2. Recurrent childhood anaplastic large cell lymphoma: a retrospective analysis of registered cases in Japan;Mori;Br J Haematol,2006

3. Haematopoietic stem cell transplantation for relapsed or refractory anaplastic large cell lymphoma: a study of children and adolescents in Japan;Fukano;Br J Haematol,2015

4. Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents;Gross;Biol Blood Marrow Transplant,2010

5. Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents-a Berlin-Frankfurt-Munster group report;Woessmann;Br J Haematol,2006

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isolated Central Nervous System Involvement after Brentuximab Vedotin Treatment for HIV-Positive ALK-Negative Anaplastic Large Cell Lymphoma;Case Reports in Hematology;2024-02-22

2. Targeting CD 30 in Lymphoid Neoplasms;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

3. Strategy for Pediatric Patients with Relapsed or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: A Review;Cancers;2023-12-07

4. Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcSé-crizotinib trial;European Journal of Cancer;2023-09

5. Future Perspective for ALK-Positive Anaplastic Large Cell Lymphoma with Initial Central Nervous System (CNS) Involvement: Could Next-Generation ALK Inhibitors Replace Brain Radiotherapy for the Prevention of Further CNS Relapse?;Pediatric Reports;2023-05-26